PATENT CLAIM ANALYSIS

Application Number: 15760918
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "400000"]

Abstract:
The present invention describes an oral pharmaceutical composition comprising cannabinoid(s), an oily liquid solvent and a co-solvent, as well as a process for preparing and the same for the treatment of neurological disorders, especially refractory epilepsy. The analytical methods used to ensure identity, quality and purity of Active Pharmaceutical Ingredient and formulation produced were validated and have defined specifications.

Claim (Index 12):
The process according to  claim 11 , wherein the dissolution step a) occurs under stirring and/or heating.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 90.0
- Lexical Diversity: 1.28302
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13302289', '14575162', '15539344', '15554209', '10218989']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7182731517686293
- 35 USC 102 Novelty (BERT): 0.5012471996415833
- Combined Prediction Score: 0.6965705565559247
- Mean Citation Score: 191.212298
- Max Citation Score: 210.63928
- Similarity Product: 134.63224767226697

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test